About
R&D
Approach
Therapeutic areas
Scientific publications
R&D centers
Scientific and medical board
Scientific partnerships
Pipeline
Overview
TOTUM•63
Lipidrive® (TOTUM•070)
TOTUM•854
TOTUM•448
Manufacturing
Investors
Presentation
Shareholder space
Financial Information
Breakdown of Share Capital
Financial Calendar
Regulatory information
Annual General Meeting
Newsroom
News
Releases
Media resources
FR
EN
Valbiotis’ regulatory information
Page d'accueil
>
Regulatory Information
Select a date :
All
2024
2023
2022
2021
2020
2019
2018
2017
Select a category :
All
Annual & half-year financial report
Company statutes
Investors presentation
Liquidity contract
Number of shares and voting rights monthly report
Universal Registration Document
All regulatory information